Altitude Sickness
📧 Sign up to get email alerts when something new happens for Altitude Sickness.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-26FDA Approved: ACETAZOLAMIDE EXTENDED-RELEASE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application from Micro Labs Limited for an extended-release formulation of acetazolamide.
-
FDA approval · 2023-08-09FDA Approved: ACETAZOLAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for acetazolamide, finalizing approval for changes to the approved generic produc…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD [Phase 3]
Phase 3 trial investigating acetazolamide to prevent impending altitude illness in patients with COPD.
-
FDA approval · 2023-01-23FDA Approved: ACETAZOLAMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Acetazolamide (generic) submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals In…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude [Phase 3]
Phase 3 trial evaluating acetazolamide effects on right heart function at rest in COPD patients traveling to high altitude, with unknown cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-07-26FDA Approved: ACETAZOLAMIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for acetazolamide filed by Strides Pharma Science Limited, authorizing an update to the generic prod…
-
FDA approval · 2019-10-17FDA Approved: ACETAZOLAMIDE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' Original Application for acetazolamide, granting approval of a generic version.
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) [Phase 3]
Phase 3 trial update on preventing altitude illness using a non-steroidal anti-inflammatory drug; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude [Phase 4]
A Phase 4 clinical trial evaluating riociguat's effects on exercise performance and pulmonary artery pressure at high altitude; the study wa…
-
CLINICAL_TRIALS withdrawal · 2017-03-13Clinical Trial Update: Inhaled Budesonide for Altitude Illness Prevention [Phase 3]
A Phase 3 clinical trial evaluating inhaled budesonide for preventing altitude sickness was withdrawn before completion.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: AZ, MZ, and the Pulmonary System Response to Hypoxia [Phase 4]
Phase 4 trial update examining how AZ and MZ influence the pulmonary system's response to hypoxia.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Effects of Mild Hypobaric Hypoxia on Sleep and Post-sleep Performance [NA]
A completed clinical trial evaluated how mild hypobaric hypoxia at altitude affects sleep quality and subsequent performance the following d…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: NSAID RCT for Prevention of Altitude Sickness [Phase 2]
Phase 2 randomized trial evaluating an NSAID for prevention of altitude sickness; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude
Goethe University's completed trial monitored cerebral tissue oxygenation and perfusion during sleep in high-altitude climbers. The study re…